Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: A brief review of current recommendations for practical purposes

European Journal of Haematology

Volumn 71, Issue 5, 2003, Pages 319-326

  Castagnola, Elio ^a   Fioredda, Francesca ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Asplenia; Infectious diseases; Prophylaxis; Vaccination

Indexed keywords

ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; CEFTRIAXONE; CIPROFLOXACIN; DIPHTHERIA TOXOID; HAEMOPHILUS VACCINE; MENINGOCOCCUS VACCINE; PENICILLIN V; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; RIFAMPICIN; TETANUS CONJUGATE HEPTAVALENT VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG; VACCINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ASPLENIA; BACTERIUM; CHILD; ENCAPSULATION; FAMILY COUNSELING; FEVER; HAEMOPHILUS INFLUENZAE; HUMAN; HYPOSPLENISM; INFANT; INFECTION; INFECTION PREVENTION; LETHALITY; NEISSERIA MENINGITIDIS; PATIENT COMPLIANCE; PATIENT EDUCATION; PEDIATRICS; PRIORITY JOURNAL; REVIEW; SPLEEN DISEASE; SPLENECTOMY; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BACTERIAL VACCINES; CHILD; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNOCOMPROMISED HOST; PATIENT EDUCATION; POSTOPERATIVE COMPLICATIONS; RISK; SPLEEN; SPLENECTOMY; SPLENIC DISEASES; VACCINATION;

EID: 0142184937     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.00158.x     Document Type: Review

References (39)

1. LUTWICK LI. Infections in asplenic patients. In: MANDELL GL, BENNETT JE, DOLIN R, eds Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone, 2000:3169-3176.
2. OPAL SM. Splenectomy and splenic dysfunction. In: ARMSTRONG D, COHEN J. eds. Infectious Diseases. London: Mosby, 1999;4:7.1-7.4.
3. VISCOLI C, CASTAGNOLA E. Factors predisposing cancer patients to infection. Cancer Treat Res 1995;79:1-30.
4. SNELLER MC. Infections in patients receiving immunosuppressive therapy for treatment of autoimmune (rheumatologic) diseases and infections following splenectomy. In: GLAUSER MP, PIZZO PA, eds. Infections in Immunocompromised Patients. London: WB Sauders, 2000:219-245.
5. HENRY PH, LONGO DL. Enlargement of lymph nodes and spleen. In: BRAUNWALD E, FAUCI AS, KASPER DL, HAUSER SL, LONGO DL, JAMESON JL, eds. Harrison's Principles of Internal Medicine. London: McGraw-Hill, 2001:360-365.
6. SUMARAJU V, LEON G, SMITH SM. Infectious complications in asplenic hosts. Infect Dis Clin North Am 2001;15:551-565.
7. DAVIDSON RN, WALL RA. Prevention and management of infections in patients without a spleen. Clin Microbiol Infect 2001;7:657-660.
8. AMERICAN ACADEMY OF PEDIATRICS. Immunocompromised Children - Asplenic Children. The Red Book on CD-ROM, Report of the Committee on Infectious Diseases, 25th edn. Elk Grove Village, IL, USA: American Academy of Pediatrics, 2000.
9. EBER SW, LANGENDORFER CM, DITZIG M, REINHARDT D, STOHR G, SOLDAN W, SCHROTER W, TCHERNIA G. Frequency of very late fatal sepsis after splenectomy for hereditary spherocytosis: impact of insufficient antibody response to pneumococcal infection. Ann Hematol 1999;78:524-528.
10. CULLINGFORD GL, WATKINS DN, WATTS AD, MALLON DF. Severe late postsplenectomy infection. Br J Surg 1991;78:716-721.
11. SCHILLING RF. Estimating the risk for sepsis after splenectomy in hereditary spherocytosis. Ann Intern Med 1995;122:187-188.
12. WORKING PARTY OF THE BRITISH COMMITTEE FOR STANDARDS IN HEMATOLOGY TASK FORCE. Guidelines for the prevention and treatment of infection in patients with an absent or disfunctional spleen. Br Med J 1996;17:430-434.
13. WAGHORN DJ. Overwhelming infection in asplenic patients: current best practice preventive measures are not being followed. J Clin Pathol 2001;54:214-218.
14. RAMACHANDRA J, BOND A, RANABOLDO C, CULLIS J. An audit of post-splenectomy prophylaxis - are we following the guidelines? Ann R Coll Surg Engl 2003;85:252-255.
15. AMERICAN ACADEMY OF PEDIATRICS. Policy statement: recommendations for the prevention of pneumococcal infections, including us of pneumococcal conjugate vaccine (Prevnar, Pneumococcal Polysaccharide vaccine), and antibiotic prophylaxis. Pediatrics 2000;106:362-376.
16. CENTERS FOR DISEASES CONTROL. Epidemiology and prevention of vaccine preventable diseases. The Pink Book, 7th edn, 2003. http://www.cdc.gov/nip/ publications/pink/.
17. SPELMAN D. Prevention of overwhelming sepsis in asplenic patients: could do better. Lancet 2001;357:2072.
18. CONRAD DA. The vulnerable host. In: JENSON HB, BALTIMORE RS, eds. Pediatric Infectious Diseases. Principles and Practice. Philadelphia: WB Saunders, 2002:1181-1186.
19. LEE HJ, KANG JH, HENRICHSEN J, KONRADSEN HB, JANG SH, SHIN HY, AHN HS, CHOI Y, HESSEL L, NAM SW. Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection. Vaccine 1995;13:1533-1538.
20. IMMUNIZATION. In: GILBERT DN, MOELLERING RC Jr, SANDE MA, eds. The Sanford Guide to Antimicrobial Therapy. Hyde Park: Antimicrobial Therapy Inc., 2003:134.
21. Recommended childhood immunization schedule - United States, 2001. Morb Mortal Wkly Rep 2001;50:7-10.
22. Prevention of infection with chemotherapy postsplenectomy bacteremia. In: GILBERT DN, MOELLERING RC Jr, SANDE MA, eds. The Sanford Guide to Antimicrobial Therapy. Hyde Park: Antimicrobial Therapy Inc., 2003:122.
23. KLINGE J, HAMMERSEN G, SCHARF J, LUTTICKEN R, REINERT RR. Overwhelming postsplenectomy infection with vaccine-type Streptococcus pneumoniae in a 12-year-old girl despite vaccination and antibiotic prophylaxis. Infection 1997;25:368-371.
24. KONRADSEN HB, RASMUSSEN C, EJSTRUD P, HANSEN JB. Antibody levels against Streptococcus pneumoniae and Haemophilus influenzae type b in a population of splenectomized individuals with varying vaccination status. Epidemiol Infect 1997;119:167-174.
25. ABILDGAARD N, NIELSEN JL Pneumococcal septicaemia and meningitis in vaccinated splenectomized adult patients. Scand J Infect Dis 1994;26:615-617.
26. CIMAZ R, MENSI C, D'ANGELO E, FANTOLA E, MILONE V, BIASIO LR, CARNELLI V, ZANETTI AR. Safety and immunogenicity of a conjugate vaccine against Haemophilus influenzae type b in splenectomized and nonsplenectomized patients with Cooley anemia. J Infect Dis 2001;183:1819-1821.
27. LAFORCE M. Use of nonroutine vaccines: hepatitis A, rabies, typhoid, and meningococcal vaccines. Infect Med 2001;18:FV22-FV26.
28. WORLD HEALTH ORGANIZATION. Emerging and Other Communicable Diseases, Surveillance and Control. Control of Epidemic Meningococcal Disease. WHO Practical Guidelines, 2nd edn. http://www.who.int/emc-documents/ meningitis/docs/whoemcbac983.pdf.
29. JODAR L, FEAVERS IM, SALISBURY D, GRANOFF DM. Development of vaccines against meningococcal disease. Lancet 2002;359:1499-1508.
30. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transpl 2000;6:1-95.
31. DYKEWICZ CA. Summary of the guidelines for preventing infections among hematopoietic stem cell transplant recipients. Clin Infect Dis 2001;33:139-144.
32. AVIGAN D, PIROFSKI L, LAZARUS HM. Vaccinations against infectious diseases following hematopoietic stem cell transplantation. Biol Bone Marrow Transpl 2001;7:171-183.
33. VOSSEN J, JOL-VAN DER ZIJDE CM, VAN TOL MDJ. The role of active and passive immunisation after stem-cell transplantation. Bone Marrow Transpl 2002;30(Suppl. 1): 5.
34. BEILKEN A, SCHRAUDER A, GRIGULL L, WELTE K, SYKORA K. Early post-transplantation vaccination with combination vaccines intended for newborns is safe and effective in children and adolescents. Bone Marrow Transpl 2002; 29:Abstract no. 145.
35. LEEMANS R, MANSON W, SNIJDER JA, SMIT JW, KLASEN HJ, THE TH, TIMENS W. Immune response capacity after human splenic autotransplantation: restoration of response to individual pneumococcal vaccine subtypes. Ann Surg 1999;229:279-285.
36. PARKKALI T, KÄYHTY H, RUUTU T, VOLIN L, ESKOLA J, RUUTU P. Immunogenicity of tetravalent meningococcal polysaccharide vaccine in adult allogeneic BMT recipients. Bone Marrow Transpl 2000;25:S199.
37. PARKKALI T. ÖLANDER RM, STENVIK M et al. Immunization of the donor in allogeneic bone marrow transplantation can facilitate subsequent post-transplantation responses of the recipient to diphteria and inactivated poliovirus vaccines; a randomized study. Bone Marrow Transpl 2002;29:Abstract no. 172.
38. RESENDE V, PETROIANU A. Functions of the splenic remnant after subtotal splenectomy for treatment of life-threatening splenic injuries. Am J Surg 2003;185:311-315.
39. HANSEN K, SINGER DB. Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited. Pediatr Dev Pathol 2001;4:105-121.